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Inactivation of host Rho GTPases is a widespread strategy employed by bacterial pathogens to manipulate mammalian
cellular functions and avoid immune defenses. Some bacterial toxins mimic eukaryotic Rho GTPase-activating proteins
(GAPs) to inactivate mammalian GTPases, probably as a result of evolutionary convergence. An intriguing question
remains whether eukaryotic pathogens or parasites may use endogenous GAPs as immune-suppressive toxins to target
the same key genes as bacterial pathogens. Interestingly, a RhoGAP domain–containing protein, LbGAP, was recently
characterized from the parasitoid wasp Leptopilina boulardi, and shown to protect parasitoid eggs from the immune
response of Drosophila host larvae. We demonstrate here that LbGAP has structural characteristics of eukaryotic
RhoGAPs but that it acts similarly to bacterial RhoGAP toxins in mammals. First, we show by immunocytochemistry
that LbGAP enters Drosophila immune cells, plasmatocytes and lamellocytes, and that morphological changes in
lamellocytes are correlated with the quantity of LbGAP they contain. Demonstration that LbGAP displays a GAP activity
and specifically interacts with the active, GTP-bound form of the two Drosophila Rho GTPases Rac1 and Rac2, both
required for successful encapsulation of Leptopilina eggs, was then achieved using biochemical tests, yeast two-hybrid
analysis, and GST pull-down assays. In addition, we show that the overall structure of LbGAP is similar to that of
eukaryotic RhoGAP domains, and we identify distinct residues involved in its interaction with Rac GTPases. Altogether,
these results show that eukaryotic parasites can use endogenous RhoGAPs as virulence factors and that despite their
differences in sequence and structure, eukaryotic and bacterial RhoGAP toxins are similarly used to target the same
immune pathways in insects and mammals.
Citation: Colinet D, Schmitz A, Depoix D, Crochard D, Poirie´ M (2007) Convergent use of RhoGAP toxins by eukaryotic parasites and bacterial pathogens. PLoS Pathog 3(12):
e203. doi:10.1371/journal.ppat.0030203
Introduction
Inactivation of host Rho GTPases, which are known to be
involved in several cellular processes, including the regu-
lation of the cytoskeletal rearrangements necessary for cell-
shape change and migration [1–3], is a widespread strategy
employed by bacterial pathogens to manipulate mammalian
cellular immunity [4]. ExoS from Pseudomonas aeruginosa, SptP
from Salmonella typhimurium or YopE from Yersinia spp. are all
virulence factors that mimic eukaryotic Rho GTPase-activat-
ing proteins (GAPs), which are important down-regulators of
Rho GTPase proteins, to target mammalian GTPases. These
bacterial toxins contain a GAP domain with no obvious
sequence similarity to eukaryotic proteins and exhibit a
different folding, suggesting that they are the product of
convergent evolution [4,5]. An intriguing question is then
whether this virulence strategy is specific to bacteria or if
RhoGAPs are similarly used by eukaryotic parasites or
pathogens to target host immunity in addition to their
endogenous cellular function.
Endoparasitoid wasps are insects that develop in the body
cavity of their host, eventually killing it, and are widely used
for biological control. Insect hosts have evolved immune
defenses against parasitoids that, if successful, result in the
formation of a melanized capsule around the wasp egg and
end with the death of the parasitoid [6,7]. In Drosophila,
plasmatocytes and lamellocytes are the main hemocyte cells
responsible for cellular encapsulation [8]. Small, rounded
plasmatocytes are the predominant form of hemocytes in
non-parasitized larvae, while large, flat lamellocytes are rarely
seen in healthy Drosophila. Following wasp oviposition, the
number of circulating hemocytes and more particularly of
lamellocytes increases [9]. Plasmatocytes are first seen
attaching to the parasitoid egg and spreading around it.
Lamellocytes then adhere to the plasmatocytes to form
multiple cell layers [10].
To circumvent host immune defenses, parasitoids have
developed different strategies mainly based on the use of
virulence factors [11,12]. In particular, parasitoid induction
of changes in morphology and adhesion properties of host
hemocytes has been repeatedly described [12], as for bacterial
pathogens of mammals, but still remains poorly understood.
This is at least partly due to the lack of information on the
molecular targets of parasitoid toxins in the host. Virulent
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strains of Leptopilina boulardi, a specialist parasitoid of D.
melanogaster, induce changes in the morphology of host
lamellocytes [9] and disrupt the encapsulation process. A
RhoGAP domain–containing protein (LbGAP, previously
known as P4) was recently characterized from parasitoid
female venom glands [13]. Interestingly, parasitism-induced
changes in host lamellocyte morphology are mimicked by
injection of LbGAP alone inside Drosophila larvae [14]. These
results led us to investigate the function of LbGAP in the
disruption of the encapsulation process, to characterize its
targets inside the host and to compare LbGAP characteristics
with those of bacterial GAP toxins. We first report that
LbGAP enters Drosophila plasmatocytes and lamellocytes and
that the quantity of LbGAP inside lamellocytes correlates
with the level of morphological changes of these cells. We
then demonstrate that LbGAP displays GAP activity and
specifically interacts with the active, GTP-bound form of the
two Drosophila Rho GTPases, Rac1 and Rac2. In addition, we
show that the overall structure of LbGAP is similar to that of
eukaryotic RhoGAP domains, and we identify distinct
residues involved in its interaction with Rac GTPases. We
thus demonstrate that eukaryotic parasites can use endoge-
nous RhoGAPs as virulence factors and that, despite their
differences in sequence and structure, eukaryotic and
bacterial RhoGAPs are similarly used to target insect and
mammalian host immune pathways. This result will help to
assess the role of evolutionary convergence in the evolution
of virulence.
Results
LbGAP Enters Drosophila Lamellocytes
To investigate whether LbGAP enters D. melanogaster
hemocytes, Drosophila larvae were parasitized by L. boulardi
females and LbGAP was detected inside hemocyte cells using
immunofluorescence. Using LbGAP-specific antibody, we
readily detected LbGAP as spots in both plasmatocytes and
lamellocytes, whereas no signal was detected in hemocytes
from non-parasitized hosts (Figure 1A). LbGAP staining was
never localized either at the periphery of the lamellocytes or
on the nucleus, thus evidencing that the protein is present
inside these very flat cells. Most plasmatocytes displayed a
high number of LbGAP spots whatever the time post-
infestation. In contrast, the number of LbGAP-stained
lamellocytes, as well as the number of lamellocytes containing
a high number of spots, significantly increased with the time
post-infestation (chi2 ¼ 126.26; df ¼ 3; p ,0.001 and chi2 ¼
19.9; df¼ 1; p ,0.01, respectively). Spots were detected inside
45% to 50% of lamellocytes 6 hours after parasitism and
inside 70% of lamellocytes 48 hours post-infestation. The
proportion of modified lamellocytes also increased with the
time post-infestation, reaching more than 60% 48 hours
following parasitism. Finally, a significant correlation was
observed between the level of morphological changes of
lamellocytes and the number of LbGAP spots they contain
when categorizing cells according to their shape and the
number of recorded spots (chi2 ¼ 402.92; df ¼ 9; p ,0.001).
Bipolar modified cells had usually considerable LbGAP
staining, whereas most discoidal unmodified lamellocytes
did not contain any spot (Figure 1B). These results thus
demonstrate the direct involvement of LbGAP in affecting
lamellocyte morphology.
LbGAP Displays a RacGAP Activity
RhoGAPs stimulate the low intrinsic GTPase activity of Rho
GTPase proteins, leading to conversion of GTP-bound active
forms of Rho GTPases to GDP-bound inactive proteins. In
order to determine if LbGAP has a GAP function in host cells,
we carried out in vitro GAP assays using LbGAP protein
produced in Escherichia coli. Experiments were performed with
human RhoA, Rac1 and Cdc42 Rho GTPases. Human Ras,
belonging to the Ras GTPase family, was included as a
control. The GAP domain from human p50 RhoGAP, which
stimulates GTPase activities of RhoA, Rac1 and Cdc42 in vitro,
was used as a positive control. Negative controls consisted in
the omission of either small G-protein or GAP protein. In
these studies, LbGAP significantly increased the GTPase
activity of human Rac1 and Cdc42 (F ¼ 198.4; df ¼ 14; p
,0.001). It did not, however, activate the conversion of GTP
to GDP for RhoA and Ras. The GAP activity towards Rac1 was
approximately four times higher than towards Cdc42,
suggesting that Rac GTPases are the preferred substrates of
LbGAP (Figure 2). However, RhoGAPs that display in vitro
activity towards multiple Rho proteins sometimes act on a
single GTPase in vivo [3,15,16], and LbGAP activity towards
Rac1 and Cdc42 thus remained to be confirmed using in vivo
assays.
LbGAP Physically Interacts with Rac GTPases
Yeast two-hybrid analysis was performed to identify the
host targets of LbGAP and to link its GAP activity with
physical in vivo interactions. In order to stabilize interactions,
we used the G12V mutated forms of Drosophila Rac1, Rac2 and
Cdc42 GTPases and the G14V mutated form of Drosophila
RhoA [17]. Each of these mutants is deficient in GTPase
activity and therefore constitutively blocked in the GTP-
bound active conformation [18]. Fusions of the GAL4
activation domain with LbGAP were expressed in yeast
together with fusions of the LexA-DNA binding domain with
either Rac1G12V, Rac2G12V, Cdc42G12V or RhoG14V.
Direct in vivo interaction of LbGAP with small GTPases was
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Author Summary
Recent data have highlighted strong similarities between insect and
mammalian immune pathways, raising the question whether they
might be similarly targeted by parasites/pathogens. Endoparasitoid
wasps are insect mortality agents that perform their development
inside their host. They are widely used in biological control, but little
is known of the way in which they disable the host immune
response. Here, we report the first characterization to our knowl-
edge of a protein–protein interaction between a parasitoid immune-
suppressive factor, LbGAP, and its host targets, thus explaining its
physiological effects on host immune cells. Strikingly, bacterial
toxins containing a domain functionally related to that of LbGAP are
known to alter human macrophages by targeting the same
molecules. Demonstration that insect and mammalian pathogens/
parasites, whether eukaryotic or prokaryotic, can use evolutionary
convergent molecules ‘‘built’’ to target the same key factors in
immune pathways, represents a new step in understanding the
evolution of host–pathogen interactions. In addition to the potential
of discovering new bioinsectides, studying virulence strategies of
insect parasites might thus help to better characterize vertebrate–
pathogen interactions and to assess the role of evolutionary
convergence in the evolution of virulence.
measured as the ability of transformed yeast to activate the
transcription of HIS3 and lacZ reporter genes, both under the
control of the LexA-binding sequences. Yeast growth on a
selective medium lacking histidine together with qualitative
detection of ß-galactosidase activity revealed that LbGAP
strongly interacts with Rac1G12V and Rac2G12V (Figure 3A).
By contrast, LbGAP showed only very weak interaction with
Cdc42G12V and no interaction with RhoAG14V.
The strength and specificity of the interaction between
LbGAP and Rac GTPases was then estimated by titration of ß-
galactosidase activity (Figure 3B). Substantial activity was
obtained using coexpression of GAL4AD-LbGAP and either
LexABD-Rac1G12V or LexABD-Rac2G12V but not in combi-
nation with non-specific sequences. The ß-galactosidase
activity resulting from the interaction between LbGAP and
Rac1G12V was similar to that obtained for the positive
control (pLex-Rasþ pGAD-Raf), supporting the idea that this
interaction is strong and specific. The ß-galactosidase activity
was approximately two times higher than that obtained for
the interaction between LbGAP and Rac2G12V, suggesting
that LbGAP interacts more strongly with Rac1G12V than with
Rac2G12V.
To further validate the yeast two-hybrid approach, we
performed a GST pull-down assay using LbGAP synthesized
in vitro in rabbit reticulocyte lysates and Rac1G12V and
Rac2G12V expressed in bacteria as a fusion with GST. LbGAP
was pulled down by Rac1G12V and Rac2G12V but not by GST
alone, thereby demonstrating the specificity of the inter-
action between LbGAP and Rac GTPases (Figure 3C).
LbGAP Interacts with the Active Form of Rac GTPases
To determine whether activation of the GTPases influences
binding to LbGAP, a second constitutively activated variant
(Q61L) and the GDP-bound inactive form (T17N) of Rac1
were used in two-hybrid assays. The leucine substitution in
Rac1Q61L results in a strongly decreased GTPase activity, as
in Rac1G12V, hence the mutant is always in the active, GTP-
bound state [19]. On the contrary, the dominant negative
Rac1T17N mutant has a severely reduced affinity for GTP and
is blocked in the inactive GDP-bound conformation [18].
Since Rac1 and Rac2 shares more than 90% sequence identity
with absolute conservation of mutagenized residues, the
following experiments were performed with Rac1.
Only the coexpression of LbGAP with Rac1G12V and
Rac1Q61L allowed yeast to grow on a selective medium
without histidine and activate the lacZ reporter gene (Figure
4A and 4B). There was no detectable interaction between
LbGAP and Rac1T17N (Figure 4A and 4B). We finally used
the T35A mutation which affects the effector loop known to
be essential for interaction of GTP-bound Rho GTPases with
Figure 1. LbGAP Enters Drosophila Lamellocytes and Plasmatocytes and Affects Lamellocyte Morphology
(A) Example of LbGAP-containing hemocytes. L: lamellocyte; P: plasmatocyte.
(B) Classification of lamellocytes into four categories according to their morphological changes. a: Unmodified lamellocyte; b: slightly modified
lamellocyte with 1 to 10 LbGAP spots; c: fairly modified lamellocyte with more than 30 LbGAP spots; d: strongly modified lamellocyte with 10 to 30
LbGAP spots. Hemocyte actin cytoskeleton was visualized using phalloidin (green). LbGAP was detected using a specific rabbit polyclonal antibody (red).
doi:10.1371/journal.ppat.0030203.g001
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specific effectors, including RacGAP proteins [19,20]. As
expected, the mutant form Rac1G12V/T35A was not able to
interact with LbGAP (Figure 4A and 4B). These results
demonstrate that only the active, GTP-bound form of Rac
GTPases binds to LbGAP.
Structural and Mechanistic Similarities
Using the Swiss Model First Approach Mode and the
similarities with structurally characterized RhoGAP domains
as support, we constructed a 3D model for LbGAP. The
predicted structure is similar to that of the eukaryotic
RhoGAP fold [21–24] and has very few differences with that
of the RhoGAP domain of ß2-chimaerin (Figure 5A), a Rac-
specific GTPase-activating protein [22]. As expected, there is
no obvious structural homology with the GAP domain of P.
aeruginosa Exoenzyme S (ExoSGAP) major toxin (Figure 5A),
whose tertiary fold was previously shown to differ from that
of eukaryotic RhoGAPs [25]. Superimposition of structures
allowed us to model the structure of Rac and LbGAP
complexed with the transition-state analogue GDP.AlF3.
The modeled complex shows Arg74 of LbGAP forming an
arginine finger that is introduced within the active site of the
GTPase in the vicinity of Rac Gln61 and GDP.AlF3 (Figure
5A). This arginine residue is conserved in all GAP proteins. In
the GAP-GTPase complex, it stabilizes the GTPase invariant
glutamine residue 61 or 63 to facilitate the catalysis of GTP to
GDP [21].
Further analysis of the LbGAP structure suggested that the
exposed residues Lys111, Arg115 and Ser190 might also
participate directly in the interaction with Rac GTPases.
Lys111 and Arg115 residues are conserved among eukaryotic
RhoGAP proteins and have been proposed or shown to be
involved in binding of Rho GTPases [21,26]. On the other
hand, Asn or Thr is usually found in place of Ser190 [21–
24,26]. We generated four site-specific mutants of LbGAP,
R74A, K111A, R115A and S190A, and compared their binding
capabilities to Rac1 with that of wild-type LbGAP. Two-
hybrid analysis revealed that the R74A and S190A mutants
were still able to interact with Rac1, although the interaction
was approximately three times lower compared to that with
the wild-type protein (Figure 5B and 5C). In contrast, there
was no detectable interaction between K111A and R115A
mutants of LbGAP and Rac1. These results indicate that
Arg74 and S190 contribute to, but are not essential for,
binding to Rac GTPases, while Lys111 and Arg115 seem to be
crucial for the interaction.
Discussion
Adhesion and cell shape changes are an essential part of
the insect cellular response against endoparasitoids, and
consequently, most of them alter hemocyte morphology or
inhibit hemocyte spreading [12,27–29]. Here, we link the
physiological effects of a parasitoid virulence factor on host
hemocytes with its molecular function and its protein targets
in the host.
LbGAP is, to our knowledge, the only GAP domain–
containing protein described as a eukaryotic virulence factor
involved in immune suppression of host defenses. Our results,
together with sequence similarities [13], characterize this
toxin as a Rac-specific GAP that specifically targets Drosophila
Rac1 and Rac2, two GTPases that are more than 90%
identical in sequence. LbGAP seems to interact more strongly
with Rac1, the significance of which remains to be assessed.
Specific targeting of Rac1 and Rac2 by a parasitoid toxin
highlights the key role of these GTPases in the regulation of
Drosophila immune defenses, a role that Rac GTPases also play
in mammalian anti-bacterial innate defenses.
Rac GTPases regulate cytoskeletal rearrangements and
adhesions necessary for cell-shape change and migration
Figure 2. LbGAP Displays GAP Activity In Vitro
Absorbance at 650 nm is correlated with the amount of Pi released from GTP-bound human Rac1, Cdc42, RhoA or Ras, either in the presence of LbGAP
or p50RhoGAP as a control or in the absence of any GAP. Grey bars: GAP activity in the presence of LbGAP. Open bars: GAP activity in the presence of
p50RhoGAP. Black bars: GAP activity in the absence of GAP. For each value, bars represent the standard error of three measurements. Different letters
above the bars designate significantly different GAP activity results (p ,0.001).
doi:10.1371/journal.ppat.0030203.g002
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[30]. Interestingly, Rac1 and Rac2 were recently demonstrated
to be non-redundantly required for successful encapsulation
of L. boulardi eggs [31,32]. Rac1 is involved in hemocyte
number increase and induction of lamellocyte formation
following infestation, as well as in hemocyte activation and
regulation of cellular adhesions in lamellocytes [32,33]. Rac2
has a specific role in hemocyte spreading following attach-
ment to the parasitoid egg and cell junction formation during
the encapsulation process [31]. Accordingly, we report that
LbGAP enters Drosophila hemocytes, plasmatocytes and
lamellocytes, and is directly involved in affecting the
morphology of circulating lamellocytes.
The question of the mode of entry of parasitoid-derived
extracellular toxins in host hemocytes has rarely been
addressed. In the CrV1 polydnavirus-encoded protein, a
coiled-coil domain containing a putative leucine zipper
seems to be required for binding and uptake by hemocytes
[34], but there is no such coiled-coil region in the LbGAP
sequence. Association of LbGAP with virus-like particles
(VLPs), which are present in L. boulardi female venom glands
[35], might facilitate its entry in host hemocytes, but still
remains to be tested experimentally. This idea is supported
both by observation of LbGAP staining as ‘‘large spots’’ inside
the hemocytes and by data on L. heterotoma VLPs [36]. In this
Figure 3. LbGAP Interacts with Rac1 and Rac2
(A) Results based on growth on selective medium lacking histidine and qualitative ß-galactosidase overlay assays. x: non-tested; -: no interaction; (þ):
very weak interaction;þþ: mean interaction; þþþþ: strong interaction.
(B) Interactions with Rac1G12V, Rac2G12V, Cdc42G12V, and RhoAG14V were assayed by measuring ß-galactosidase activity in total protein extracts.
Grey bars: ß-galactosidase activity in the presence of LbGAP. Black bars: ß-galactosidase activity in the presence of T antigen. Open bar: Positive control
interaction between Ras and Raf. For each value, bars represent the standard error of three measurements.
(C) GST pull-down assay. LbGAP protein was synthesized using rabbit reticulocyte lysates and mixed with equal amounts of GST-Rac1G12V or GST
proteins bound to Glutathione Sepharose beads. After incubation, the mixtures were subjected to SDS PAGE analysis. 1: LbGAP þ GST-Rac1G12V. 2:
LbGAPþ GST-Rac2G12V. 3: LbGAPþ GST. 4: LbGAP alone. 5: GST-Rac1G12V alone. 6: GST-Rac1G12V alone.
doi:10.1371/journal.ppat.0030203.g003
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parasitoid, VLPs, that somehow affect lamellocyte morphol-
ogy, were described free in the cytoplasm of lamellocytes but
restricted to phagocytic vesicles of plasmatocytes [36].
LbGAP has all characteristics of a RhoGAP toxin. However,
in contrast to bacterial GAP toxins, it shares broad structural
and mechanistic similarities with eukaryotic RhoGAPs and
probably corresponds to an endogenous RhoGAP protein.
Bacterial GAP toxins lead to the disruption of actin filaments
in mammalian host cells and inhibition of bacterial uptake
[37]. Interestingly, expression of ExoSGAP was also shown to
inhibit Rac GTPase–dependent signalling in Drosophila and
alter its anti-bacterial immune defense [38].
An open area of research is now to assess the importance of
RhoGAP molecules as virulence factors in parasitoid wasps
and other eukaryotic parasite/pathogens. Interestingly, a
RhoGAP domain–containing protein, VLP2, has been de-
scribed in another VLP-bearing parasitoid species, Venturia
canescens [39], but its involvement as a virulence factor
remains to be tested. Other regulators of Rho GTPase
function, such as GDP/GTP exchange factors (GEFs), are used
by bacteria to circumvent host immunity [4], and might also
be used as eukaryotic toxins. As a whole, our data suggest that
considering well-studied prokaryotic toxins might help
deciphering virulence of eukaryotic parasites.
Research in the last ten years has provided evidence of high
similarities between the Drosophila immune response and
mammalian innate immunity [40,41] and has highlighted the
interest of Drosophila as a model system for studying the
evolution of haematopoiesis [42]. Recent data suggest that
insect and mammalian parasite/pathogens might alter similar
host immune pathways by injecting functionally related
toxins [43,44]. We establish here that these functionally
related toxins can also target the same key molecules. In
addition to the potential of discovering new bioinsectides,
studying virulence strategies of insect parasites might thus
help to better characterize vertebrate–pathogen interactions
and to assess the role of evolutionary convergence in the
evolution of virulence.
Materials and Methods
Origin of strains. The origin of the Leptopilina boulardi Ism strain
(Gif stock number 431), virulent on Drosophila melanogaster, has been
previously described [45]. The D. melanogaster hopTum-l strain [46], a
tumour-forming stock, was provided by Dr. Hsiling Chiu (City College
of City University of New York). Its genotype is y v hopTum-l on
chromosome X. Larvae homozygous or hemizygous for the mutation,
identified by their yellow mouth hooks, were used in the experiments
since they produce an overabundance of lamellocytes.
Immunocytochemistry. Groups of 30 HopTum-l larvae were para-
sitized by five L. boulardi females for 4 hours. The hemocytes were bled
from larvae 6, 15, 24 or 48 hours post-parasitism and allowed to
attach to a glass slide for 1 hour. The cells were fixed for 10 min with
4% paraformaldehyde, washed in PBS, permeabilized in 0.1% Triton
and blocked in 2% BSA. The samples were first incubated with the
rabbit polyclonal anti-LbGAP [13] antibody and then with a
secondary anti-rabbit antibody conjugated with FluoProbe 494
(Interchim) together with Phalloidin-X5-FluoProbe 505 (Interchim)
Figure 4. LbGAP Specifically Interacts with the Active, GTP-Bound Form of Rac GTPases
(A) Summary of results obtained for LbGAP interaction with Rac1G12V, Rac1Q61L, Rac1T17N, and Rac1G12V/T35A by growth on selective medium
lacking histidine and qualitative ß-galactosidase overlay assays. x: non-tested; - : no interaction; þþþ, þþþþ: strong interaction.
(B) Interactions with Rac1G12V, Rac1Q61L, Rac1T17N, and Rac1G12V/T35A assayed by measuring ß-galactosidase activity in total protein extracts. Grey
bars: ß-galactosidase activity in the presence of LbGAP. For each value, bars represent the standard error of three measurements.
doi:10.1371/journal.ppat.0030203.g004
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to visualize F-actin. The slides were mounted using fluorescent mount
medium (DakoCytomation). Observations were performed under
fluorescence microscopy (Axioplan 2, Zeiss) and digital pictures were
taken under 1003 oil objective with an AxioCam Zeiss camera
controlled by the Axiovision 4 software (Zeiss).
Experiments were performed in triplicate for each post-parasitism
time condition and lamellocytes and plasmatocytes were observed for
LbGAP and F-actin staining. Lamellocytes were classified into four
categories according to their shape (unmodified, slightly modified,
fairly modified or strongly modified) and the number of recorded
LbGAP spots (no spots, 1 to 10 spots, 11 to 30 spots, more than 30
spots). Three hundred lamellocytes were observed and counted for
each sample.
Statistical analysis was performed using the SAS software. The
three variables, ‘‘Lamellocyte morphology’’, ‘‘Lamellocyte staining’’,
and ‘‘Time post-infestation’’, were entered as categorical variables.
Relationships between these variables were then analyzed using
multiple logistic regression categorical data modeling (CATMOD),
with parameters derived using the maximum likelihood (ML) method.
Data were analysed in order to test independence between
‘‘Lamellocyte morphology’’ or ‘‘Lamellocyte staining’’ and ‘‘Time
post-infestation’’ and between ‘‘Lamellocyte staining’’ and ‘‘Lamello-
cyte morphology’’.
In vitro GAP assays. LbGAP was produced as a fusion to GST and
then released through cleavage with the Xa factor as previously
reported [13]. In vitro GAP assays were performed in triplicates using
Figure 5. Molecular Modeling of LbGAP and In Vitro Mutagenesis
(A) Tertiary structure of the Rac1-LbGAP complex and comparison of LbGAP structure with ß2-ChimaerinGAP and ExoSGAP folds. The LbGAP structure is
colored red, the ß2-ChimaerinGAP structure is colored green, the ExoSGAP structure is colored orange, and the Rac1 structure is colored blue. Helices
are shown as ribbons. Protruding LbGAP Arg74, ß2-ChimaerinGAP Arg311, and ExoSGAP Arg146 are shown as sticks and colored yellow. GDP and AlF3
are shown as ball-and-sticks models and colored in magenta.
(B) Summary of results obtained for Rac1G12V interaction with LbGAPR74A, LbGAPK111A, LbGAPR115A, and LbGAPS190A mutants by growth on
selective medium lacking histidine and qualitative ß-galactosidase overlay assays. -: no interaction; þ: weak interaction;þþþ: strong interaction.
(C) Interactions with LbGAPR74A, LbGAPK111A, LbGAPR115A, and LbGAPS190A mutants assayed by measuring ß-galactosidase activity in total protein
extracts. Grey bars: ß-galactosidase activity in the presence of LbGAP. For each value, bars represent the standard error of all three measurements.
doi:10.1371/journal.ppat.0030203.g005
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the RhoGAP Assay Biochem Kit from Cytoskeleton. Occurrence of
treatment-dependent differences in GAP activities was tested using
ANOVA analyses, followed by pairwise comparisons using Fisher’s
Least Significant Difference (LSD) test, and the Systat software
package.
Yeast two-hybrid analysis. The LbGAP cDNA was amplified by RT-
PCR using mRNA from L. boulardi female long gland extracts and
inserted into the pGADT7 vector by homologous recombination in
yeast strain JD53 (MATa, his3–200, leu2–3112, lys2–801, trp1–63,
ura3–52). The LexA DNA binding domain plasmids expressing
mutated forms of Rho GTPases were kindly provided by Dr.
Fauvarque (De´partement de Biologie Mole´culaire et Structurale,
CEA Grenoble) and transformed in yeast strain L40 (MATa, trp1, leu2,
ade2, GAL4, lexAops-HIS3, lexAops-lacZ) using Gietz protocol [47].
Pairs of interactions were examined individually by mating JD53
and L40 yeast colonies according to the Yeast Protocols Handbook
PT3024–1 (Clontech Laboratories). The plasmids expressing Rho
GTPases were tested against pGADT7 empty vector and pGADT7-T
control vector, encoding a fusion between the GAL4 activation
domain and SV40 large T-antigen. Reciprocally, the plasmid
producing LbGAP was tested against pLex-Ras and pLex-Lamin
control vectors. Interaction between pGAD-Raf and pLex-Ras was
used as a positive control.
Interactions were tested by spotting five-fold serial dilutions of
cells on minimal medium lacking histidine and supplemented with 3-
amino-triazole at 0.5 mM to reduce the number of false positives. ß-
galactosidase activity was then revealed on plates as previously
described [48]. Finally, quantification of ß-galactosidase activity in
liquid assays was performed according to the Yeast Protocols
Handbook PT3024–1 (Clontech Laboratories).
GST pull-down assay. The production of the GST-Rac1G12V and
the GST-Rac2G12V fusion proteins and GST alone was performed
according to the GST Gene Fusion System Handbook (Amersham
Biosciences). For the pull-down assay, equal amounts of GST-
Rac1G12V, GST-Rac2G12V or GST alone were added to 10 ll of
rabbit reticulocyte lysates (TNT Quick Coupled Transcription/
Translation Systems, Promega) programmed with pGADT7-LbGAP
in the presence of TranscendTM Biotin-Lysil-tRNA (Promega). After
incubation overnight with 20 ll glutathione-Sepharose, proteins
bound to the Sepharose beads were washed, resolved by SDS-PAGE
and electroblotted to an Immobilon-P Transfer Membrane (Milli-
pore). Biotinylated proteins were visualized using the TranscendTM
Non-Radioactive Translation Detection System (Promega).
Molecular modeling of LbGAP. The RhoGAP domain of LbGAP
was modeled by homology using Swiss Model [49–51] with human ß2-
chimaerin [22] and chicken Graf [23] structures as templates. The
model quality was assessed by Whatcheck [52] and Procheck [53]. The
structure of Rac and LbGAP complexed with the transition-state
analogue GDP.AlF3 was modeled by superimposing the RhoGAP
domain of the p50RhoGAP/RhoA-GDP.AlF4 complex [21] on LbGAP.
The structure of Rac-GDP.AlF3 as observed in complex with
ExoSGAP [25] was then superimposed on the RhoA portion of the
p50RhoGAP/RhoA-GDP.AlF4- structure. The molecular structures
were visualized and superimposed using PyMol (http://pymol.
sourceforge.net/).
In vitro mutagenesis. The R74A, K111A, R115A and S190A
mutations were introduced into the LbGAP cDNA using the
QuickChange XL Site-Directed Mutagenesis Kit (Stratagene).
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